Speech-Language Pathologists in Gibsonville, NC Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Champion Therapy Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Brownbark Ln, Gibsonville, NC 27249 Phone: 336-213-3352    Fax: 336-446-4206

Cynthia Carter Champion, MS, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Brownbark Ln, Gibsonville, NC 27249 Phone: 336-213-3352    Fax: 336-446-4206

Ms. Gayle Renee Compton, M.S. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Piedmont Ave, Gibsonville, NC 27249 Phone: 336-449-4055    Fax: 336-449-7368

Mrs. Melissa Sharpe May, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6103 Oak Wind Dr, Gibsonville, NC 27249 Phone: 336-697-2378    Fax: 336-697-2378

News Archive

American Heart Association supports salt reduction initiative

The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.

Positive results from Lexicon's LX4211 Phase 2b trial on type 2 diabetes

Lexicon Pharmaceuticals, Inc., announced today that LX4211, an investigational, oral, dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2), showed substantial, dose-dependent, statistically-significant reductions in hemoglobin A1c (HbA1c) in a Phase 2b trial in patients diagnosed with poorly-controlled type 2 diabetes who were concurrently treated with metformin, an established diabetes therapy.

Massive study looks at history of COVID-19 in Catalonia, Spain

A massive and important new study published on the preprint server medRxiv* in July 2020 sets out a comprehensive picture of the COVID-19 outbreak in Catalonia, Spain. It fills in a void in the current research, with its grand scale and detailed analysis.

FDA takes more time to decide on the fate of BMS & Pfizer's joint venture anticlotting drug Eliquis

The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That's three months later than originally scheduled.

Study: Children who eat fish at least once a week sleep better and have higher IQ scores

Children who eat fish at least once a week sleep better and have IQ scores that are 4 points higher, on average, than those who consume fish less frequently or not at all, according to new findings from the University of Pennsylvania published this week in Scientific Reports, a Nature journal.

Read more Medical News

› Verified 4 days ago